Prediction of Busulfan Clearance by Predose Plasma Metabolomic Profiling-Reference-Cited by-同舟云学术

Prediction of Busulfan Clearance by Predose Plasma Metabolomic Profiling

Published:2022-12-26 Issue:2 Volume:113 Page:370-379
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

McCune Jeannine S.¹^ORCID,Navarro Sandi L.²^ORCID,Baker K. Scott³⁴^ORCID,Risler Linda J.⁵,Phillips Brian R.⁵,Randolph Timothy W.³^ORCID,Shireman Laura⁵,Schoch H. Gary³^ORCID,Deeg H. Joachim³⁶^ORCID,Zhang Yuzheng³,Men Alex⁵,Maton Loes⁷,Huitema Alwin D. R.⁷⁸⁹

Affiliation:

1. Department of Hematologic Malignancies Translational Sciences City of Hope Duarte California USA

2. Public Health Sciences Division Fred Hutchinson Cancer Center Seattle Washington USA

3. Clinical Research Division Fred Hutchinson Cancer Center Washington Seattle USA

4. Department of Pediatrics University of Washington Washington Seattle USA

5. Department of Pharmaceutics University of Washington Seattle Washington USA

6. Department of Medicine University of Washington Seattle Washington USA

7. Department of Pharmacy & Pharmacology Netherlands Cancer Institute Amsterdam The Netherlands

8. Department of Pharmacology, Princes Maxima & Pharmacology Netherlands Cancer Institute Amsterdam The Netherlands

9. Department of Clinical Pharmacy University Medical Center Utrecht Utrecht The Netherlands

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2794

Reference34 articles.

1. Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

2. Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement

3. Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients

4. Variation in Prescribing Patterns and Therapeutic Drug Monitoring of Intravenous Busulfan in Pediatric Hematopoietic Cell Transplant Recipients

5. Prediction of intravenous busulfan clearance by endogenous plasma biomarkers using global pharmacometabolomics

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen;Transplantation and Cellular Therapy;2024-07

2. Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients;Therapeutic Drug Monitoring;2024-06-14

3. Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing;Journal of Pharmacokinetics and Pharmacodynamics;2024-03-23

4. Isoamyl Nitrite Activated Primary Sulfonamide to Sulfonyl Bromide and Sulfonyl Chloride;Chinese Journal of Organic Chemistry;2024

5. Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management;Journal of Pharmaceutical Analysis;2024-01